Associated Complications and survival rate after thyroid cancer operation

Dilshad Hamad Mustafa ,, Baderkhan Saeed Ahmed
{"title":"Associated Complications and survival rate after thyroid cancer operation","authors":"Dilshad Hamad Mustafa ,, Baderkhan Saeed Ahmed","doi":"10.26505/djm.v25i2.1045","DOIUrl":null,"url":null,"abstract":"Background: Thyroid cancer is a common endocrine neoplasm in all parts of the world and the commonest histologic type is PTC. The Treatment of choice for this pathology is surgery and it has associated complications commonly hypocalcaemia and RLNP with specific survival rates. Objective: To find out the incidence of associated complications of thyroid surgery with their survival rates. Patients and Methods: We analysed data from 574 patients diagnosed with TC from 2018 to 2021, using the Kaplan-Meier method and log-rank test to determine complications of thyroid surgery and overall survival. Results: The mean age of the patients was 41.3 (±14.1) years, there were 92(16%) patients aged >55 years and 482(84%) patients ≤ 55 years old at the time of diagnosis. Females were more affected by the female: male ratio (3.9: 1); 456 cases occurred in females (79.4%) and 118 in males (20.6%). The most common modes of presentation were neck lump in 492 (85.7%) patients and tumor size ≤4 cm in 495(86.3) patients. The commonest stage at diagnosis is stage I 494(86.1%), of the cases confined to the thyroid gland. The main surgical procedure was total thyroidectomy for 470(81.9%) patients. The common complications are hypocalcemia 70(12.6%) and 46(8.3%) developed RLN damage. The mean survival time was (55.87) months (CI = 54.86-56.88 months), but varies according to age < 55 years (58.02 months) and ≥ 55 years (44.426 months). Sex female has a better prognosis (56.540 months) while males (52.40 months). stage I mean survival was (58.79months) while a decrease in stage IV mean survival was (23.36 months). Conclusion: The incidence of complications associated with TC surgery in our study is close to what was published elsewhere in the world with slight differences in percentages of each complication. The survival rate drops within the available ranges.","PeriodicalId":11202,"journal":{"name":"Diyala Journal of Medicine","volume":"15 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diyala Journal of Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26505/djm.v25i2.1045","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Thyroid cancer is a common endocrine neoplasm in all parts of the world and the commonest histologic type is PTC. The Treatment of choice for this pathology is surgery and it has associated complications commonly hypocalcaemia and RLNP with specific survival rates. Objective: To find out the incidence of associated complications of thyroid surgery with their survival rates. Patients and Methods: We analysed data from 574 patients diagnosed with TC from 2018 to 2021, using the Kaplan-Meier method and log-rank test to determine complications of thyroid surgery and overall survival. Results: The mean age of the patients was 41.3 (±14.1) years, there were 92(16%) patients aged >55 years and 482(84%) patients ≤ 55 years old at the time of diagnosis. Females were more affected by the female: male ratio (3.9: 1); 456 cases occurred in females (79.4%) and 118 in males (20.6%). The most common modes of presentation were neck lump in 492 (85.7%) patients and tumor size ≤4 cm in 495(86.3) patients. The commonest stage at diagnosis is stage I 494(86.1%), of the cases confined to the thyroid gland. The main surgical procedure was total thyroidectomy for 470(81.9%) patients. The common complications are hypocalcemia 70(12.6%) and 46(8.3%) developed RLN damage. The mean survival time was (55.87) months (CI = 54.86-56.88 months), but varies according to age < 55 years (58.02 months) and ≥ 55 years (44.426 months). Sex female has a better prognosis (56.540 months) while males (52.40 months). stage I mean survival was (58.79months) while a decrease in stage IV mean survival was (23.36 months). Conclusion: The incidence of complications associated with TC surgery in our study is close to what was published elsewhere in the world with slight differences in percentages of each complication. The survival rate drops within the available ranges.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
甲状腺癌手术后的相关并发症和存活率
背景:甲状腺癌是世界各地常见的内分泌肿瘤,最常见的组织学类型是 PTC。这种病变的首选治疗方法是手术,但手术会产生相关并发症,常见的并发症有低钙血症和RLNP,且生存率较低。 目的了解甲状腺手术相关并发症的发生率及其存活率。 患者和方法我们分析了2018年至2021年确诊为TC的574例患者的数据,采用Kaplan-Meier法和对数秩检验确定甲状腺手术并发症和总生存率。 结果:患者的平均年龄为41.3(±14.1)岁,诊断时年龄大于55岁的患者有92人(16%),小于55岁的患者有482人(84%)。女性患者较多,男女比例为 3.9:1;女性患者 456 例(79.4%),男性患者 118 例(20.6%)。492例(85.7%)患者最常见的发病方式是颈部肿块,495例(86.3%)患者的肿瘤大小≤4厘米。最常见的诊断分期是I期,494例(86.1%)患者的肿瘤局限于甲状腺。470例(81.9%)患者的主要手术方式是甲状腺全切除术。常见并发症为低钙血症70例(12.6%)和RLN损伤46例(8.3%)。平均存活时间为(55.87)个月(CI = 54.86-56.88个月),但因年龄而异,小于55岁(58.02个月),大于55岁(44.426个月)。女性预后较好(56.540 个月),而男性预后较差(52.40 个月)。I 期患者的平均生存期为 58.79 个月,而 IV 期患者的平均生存期缩短为 23.36 个月。 结论在我们的研究中,TC 手术相关并发症的发生率与世界其他地方公布的情况接近,只是每种并发症的发生率略有不同。存活率在现有范围内下降。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Evaluation of Some the Cytotoxic Effects of Edible Mushroom Extracts Pleurotus ostreatus The Impact of Practicing Exercise and Risk Factors Categorize in Osteoporotic Concerning Postmenopausal Women (Analytical study using binary logistic regression) Seroprevalence study of Parvovirus B19 among women with miscarriage in Mosul city Localization of the position of vital anatomical structures in the lateral wall of maxillary sinus during different surgical intervention using cone beam computed tomography Effect of saliva of patients with leukemia on surface hardness and roughness of enamel and dental composite resin during chemotherapy regimen: An – Invitro study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1